Celsion CorpAdd to My Watchlist

CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 2.62
  • 0.06  -2.24%
    Today's Change
  • 2.68
    Previous Close
  • Today
    52 Week Low - High
10:49 am ET 3/31/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding20 million
Market Cap$52 million
Return on Equity ttm-81.08%
Last DividendCLSN:US does not pay a dividend
EPS: Year Actual ttm-1.342
EPS: Year Est. 12/15 ttm-1.360
EPS: Quarterly Actual 12/14 -0.32
EPS: Quarterly Est. 3/15 -0.33
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-45.26
Company Description
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Net Income$-25 million
Total Assets$46 million
Web Sitewww.celsion.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!